Literature DB >> 21704629

Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice.

V Abraira1, J C Alvarez-Cermeño, R Arroyo, C Cámara, B Casanova, S Cubillo, C de Andrés, C Espejo, O Fernández, J Ferrer, M A Figueredo, A García-Merino, M I García-Sánchez, J A García-Trujillo, M Gómez, C González-Oria, A Gosis, G Izquierdo, J Jímenez, M López-Trascasa, X Montalbán, M J Moreno, D Muñoz, V Nuñez, A Muriel, J Navarro, J Olascoaga, C Oreja-Guevara, A Prada, E Ramil, C Ramo-Tello, C Rodríguez, E Rodríguez, F Rodríguez-Frías, A Rodríguez-Antigüedad, J J Rodríguez-Molina, E Ruiz, A Saiz, E Sarasola, M Simó, J Yagüe, L M Villar.   

Abstract

An early and accurate diagnosis of multiple sclerosis (MS) is very important, since it allows early treatment initiation, which reduces the activity of the disease. Oligoclonal IgG band (OCGB) detection is a good ancillary tool for MS diagnosis. However, it was argued that its usefulness was limited by the high interlaboratory variability. In the last years, different techniques for OCGB detection have appeared. We performed a blinded aleatorized multicenter study in 19 Spanish hospitals to assess the accuracy and reproducibility of OCGB detection in this new scenario. We studied cerebrospinal fluid (CSF) and serum samples from 114 neurological patients. Every hospital contributed to the study with triplicated pairs of CSF and serum samples of six patients and analyzed 18 different samples. Global analysis rendered a sensitivity of 92.1%, a specificity of 95.1% and a Kappa value of 0.81. This shows that current techniques for OCGB detection have good accuracy and a high interlaboratory reproducibility and thus, represent a good tool for MS diagnosis. When we analyzed separately the different techniques used for OCGB detection, the highest concordance was observed in western blot with alkaline phosphatase detection (kappa=0.91). This indicates that high sensitivity techniques improve the reproducibility of this assay.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21704629     DOI: 10.1016/j.jim.2011.06.009

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  CSF abnormalities can be predicted by VEP and MRI pathology in the examination of optic neuritis.

Authors:  Henrik Horwitz; Matilda Degn; Signe Modvig; Henrik B W Larsson; Benedikte Wanscher; Jette L Frederiksen
Journal:  J Neurol       Date:  2012-06-06       Impact factor: 4.849

2.  Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis.

Authors:  Steffen Halbgebauer; André Huss; Mathias Buttmann; Petra Steinacker; Patrick Oeckl; Isabel Brecht; Andreas Weishaupt; Hayrettin Tumani; Markus Otto
Journal:  J Neurol       Date:  2016-03-19       Impact factor: 4.849

Review 3.  B Cells and Autoantibodies in Multiple Sclerosis.

Authors:  Anne-Katrin Pröbstel; Nicholas S R Sanderson; Tobias Derfuss
Journal:  Int J Mol Sci       Date:  2015-07-21       Impact factor: 5.923

4.  No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients.

Authors:  Madlyne Becker; Clotilde Latarche; Emilie Roman; Marc Debouverie; Catherine Malaplate-Armand; Francis Guillemin
Journal:  BMC Neurol       Date:  2015-05-13       Impact factor: 2.474

5.  Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis.

Authors:  Gabriella Passerini; Gloria Dalla Costa; Francesca Sangalli; Lucia Moiola; Bruno Colombo; Massimo Locatelli; Giancarlo Comi; Roberto Furlan; Vittorio Martinelli
Journal:  Mult Scler Int       Date:  2016-12-28

Review 6.  Diversity of immune cell types in multiple sclerosis and its animal model: Pathological and therapeutic implications.

Authors:  Yun Cheng; Li Sun; Zhongxiang Xie; Xueli Fan; Qingqing Cao; Jinming Han; Jie Zhu; Tao Jin
Journal:  J Neurosci Res       Date:  2017-01-13       Impact factor: 4.164

7.  Free kappa light chains in cerebrospinal fluid as a biomarker to assess risk conversion to multiple sclerosis.

Authors:  P Menéndez-Valladares; M I García-Sánchez; P Cuadri Benítez; M Lucas; M Adorna Martínez; V Carranco Galán; J L García De Veas Silva; C Bermudo Guitarte; G Izquierdo Ayuso
Journal:  Mult Scler J Exp Transl Clin       Date:  2015-12-16

8.  Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.

Authors:  C E Leurs; Ham Twaalfhoven; B I Lissenberg-Witte; V van Pesch; I Dujmovic; J Drulovic; M Castellazzi; T Bellini; M Pugliatti; J Kuhle; L M Villar; J C Alvarez-Cermeño; R Alvarez-Lafuente; H Hegen; F Deisenhammer; L M Walchhofer; E Thouvenot; M Comabella; X Montalban; L Vécsei; C Rajda; D Galimberti; E Scarpini; A Altintas; K Rejdak; J L Frederiksen; G Pihl-Jensen; Peh Jensen; M Khalil; M M Voortman; F Fazekas; A Saiz; D La Puma; M Vercammen; L Vanopdenbosch; Bmj Uitdehaag; J Killestein; C Bridel; C Teunissen
Journal:  Mult Scler       Date:  2019-05-08       Impact factor: 6.312

9.  The clinical significance of single or double bands in cerebrospinal fluid isoelectric focusing. A retrospective study and systematic review.

Authors:  Harald Hegen; Anne Zinganell; Michael Auer; Florian Deisenhammer
Journal:  PLoS One       Date:  2019-04-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.